Frequent reversible membrane damage in peripheral blood B cells in human T cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP)

Clinical and Experimental Immunology

Volumn 120, Issue 2, 2000, Pages 307-316

  Furukawa, Y ^a   Bangham, C R M ^a   Taylor, G P ^a   Weber, J N ^a   Osame, M ^b  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Annexin V; Apoptosis; B lymphocyte; HAM TSP; Membrane damage

Indexed keywords

CD19 ANTIGEN; LIPOCORTIN 5; PHOSPHATIDYLSERINE;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNOPATHOGENESIS; MEMBRANE DAMAGE; PRIORITY JOURNAL; SPASTIC PARAPLEGIA; SPINAL CORD INFECTION; T LYMPHOCYTE SUBPOPULATION;

ADULT; ANNEXIN A5; ANTIBODIES, ANTICARDIOLIPIN; ANTIGENS, CD19; ANTIGENS, CD95; APOPTOSIS; B-LYMPHOCYTES; BETA 2-GLYCOPROTEIN I; BIOLOGICAL MARKERS; CASPASE 3; CASPASES; CELL MEMBRANE; CELLS, CULTURED; ENZYME ACTIVATION; GLYCOPROTEINS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; PARAPARESIS, TROPICAL SPASTIC; STAINING AND LABELING; TIME FACTORS; VIRAL LOAD;

EID: 0034111419     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2000.01211.x     Document Type: Article

References (38)

1. 1 Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A, de Thé G. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985; 2:407-10.
2. 2 Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, Matsumoto M, Tara M. HTLV-I associated myelopathy, a new clinical entity. Lancet 1986; 1:1031-2.
3. 3 Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980; 77:7415-9.
4. 4 Yoshida M, Miyoshi I, Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 1982; 79:2031-5.
5. 5 Yoshida M, Osame M, Kawai H et al. Increased replication of HTLV-I in HTLV-I-associated myelopathy. Ann Neurol 1989; 26:331-5.
6. 6 Jacobson S, Shida H, McFarlin DE, Fauci AS, Koenig S. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature 1990; 348:245-8.
7. 7 Parker CE, Daenke S, Nightingale S, Bangham CR. Activated, HTLV-I-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis. Virology 1992; 188:628-36.
8. 8 Van Parijs L, Abbas AK. Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science 1998; 280:243-8.
9. 9 Debatin KM, Goldman CK, Waldmann TA, Krummer PH. APO-I-induced apoptosis of leukemia cells from patients with adult T-cell leukemia. Blood 1993; 81:2972-7.
10. 10 Yamada T, Yamaoka S, Goto T, Nakai M, Tsujimoto Y, Hatanaka M. The human T-cell leukemia virus type I Tax protein induces apoptosis which is blocked by the Bcl-2 protein. J Virol 1994; 68:3374-9.
11. 11 Chlichlia K, Moldenhauer G, Daniel PT, Busslinger M, Gazzolo L, Schirrmacher V, Khazaie K. Immediate effects of reversible HTLV-I tax function: T-cell activation and apoptosis. Oncogene 1995; 10:269-77.
12. 12 Copeland KF, Haaksma AG, Goudsmit J, Krammer PH, Heeney JL. Inhibition of apoptosis in T cells expressing human T cell leukemia virus type I Tax. AIDS Res Hum Retrovir 1994; 10:1259-68.
13. 13 Brauweiler A, Garrus JE, Reed JC, Nyborg JK. Repression of bax gene expression by the HTLV-I Tax protein: implications for suppression of apoptosis in virally infected cells. Virology 1997; 231:135-40.
14. 14 Macho A, Castedo M, Marchetti P et al. Mitochondrial dysfunctions in circulating T lymphocytes from human immunodeficiency virus-1 carriers. Blood 1995; 86:2481-7.
15. 15 Carbonari M, Cibati M, Cherchi M, Sbarigia D, Pesce AM, DellAnna L, Modica A, Fiorilli M. Detection and characterization of apoptotic peripheral blood lymphocytes in human immunodeficiency virus infection and cancer chemotherapy by a novel flow immunocytometric method. Blood 1994; 83:1268-77.
16. 16 Samuelsson A, Sönnerborg A, Heuts N, Cöster J, Chiodi F. Progressive B cell apoptosis and expression of Fas ligand during human immunodeficiency virus type 1 infection. AIDS Res Hum Retrovir 1997; 13:1031-8.
17. 17 Martin SJ, Reutelingsperger CP, McGahon AJ, Rader JA, van Schie RC, LaFace DM, Green DR. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med 1995; 182:1545-56.
18. 18 van Engeland M, Nieland LJ, Ramaekers FC, Schutte B, Reutelingsperger CP. Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 1998; 31:1-9.
19. 19 Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST, van Oers MH. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 1994; 84:1415-20.
20. 20 Casciola Rosen L, Rosen A, Petri M, Schlissel M. Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: implications for coagulation events and antigenic spread in systemic lupus erythematosus. Proc Natl Acad Sci USA 1996; 93:1624-9.
21. 21 Tosswill JHC, Taylor GP, Clewley JP, Weber JN. Quantification of proviral DNA load in HTLV-I infections. J Virol Methods 1998; 75:21-26.
22. 22 Beilke MA, In DR, Gravell M et al. In situ hybridization detection of HTLV-I RNA in peripheral blood mononuclear cells of TSP/HAM patients and their spouses. J Med Virol 1991; 33:64-71.
23. 23 Chapple MR, MacLennan IC, Johnson GD. A phenotypic study of B lymphocyte subpopulations in human bone marrow. Clin Exp Immunol 1990; 81:166-72.
24. 24 Lens SM, Tesselaar K, den Drijver BF, van Oers MH, van Lier RA. A dual role for both CD40-ligand and TNF-alpha in controlling human B cell death. J Immunol 1996; 156:507-14.
25. 25 Vermes I, Haanen C, Richel DJ, Schaafsma MR, Kalsbeek Batenburg E, Reutelingsperger CP. Apoptosis and secondary necrosis of lymphocytes in culture. Acta Haematol 1997; 98:8-13.
26. 26 Ashman RF, Peckham D, Stunz LL. Regulation of B cell apoptosis. Adv Exp Med Biol 1996; 406:145-54.
27. 27 Bratton DL, Fadok VA, Richter DA, Kailey JM, Guthrie LA, Henson PM. Appearance of phosphatidylserine on apoptotic cells requires calcium-mediated nonspecific flip-flop and is enhanced by loss of the aminophospholipid translocase. J Biol Chem 1997; 272:26159-65.
28. 28 Castedo M, Hirsch T, Susin SA, Zamzami N, Marchetti P, Macho A, Kroemer G. Sequential acquisition of mitochondrial and plasma membrane alterations during early lymphocyte apoptosis. J Immunol 1996; 157:512-21.
29. 29 Golstein P. Cell death: TRAIL and its receptors. Curr Biol 1997; 7:750-3.
30. 30 Takeya H, Mori T, Gabazza EC et al. Anti-betal-glycoprotein I (beta2GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the beta2GPI binding to phospholipids. J Clin Invest 1997; 99:2260-8.
31. 31 Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 1992; 148:2207-16.
32. 32 Savill J, Dransfield I, Hogg N, Haslett C. Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis. Nature 1990; 343:170-3.
33. 33 Ren Y, Silverstein RL, Allen J, Savill J. CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis. J Exp Med 1995; 181:1857-62.
34. 34 Flora PK, Gregory CD. Recognition of apoptotic cells by human macrophages: inhibition by a monocyte/macrophage-specific monoclonal antibody. Eur J Immunol 1994; 24:2625-32.
35. 35 Bombeli T, Karsan A, Tait JF, Harlan JM. Apoptotic vascular endothelial cells become procoagulant. Blood 1997; 89:2429-42.
36. 36 Flynn PD, Byrne CD, Baglin TP, Weissberg PL, Bennett MR. Thrombin generation by apoptotic vascular smooth muscle cells. Blood 1997; 89:4378-84.
37. 37 Reutelingsperger CP, van Heerde WL. Annexin V, the regulator of phosphatidylserine-catalyzed inflammation and coagulation during apoplosis. Cell Mol Life Sci 1997; 53:527-32.
38. 38 Nakagawa M, Izumo S, Ijichi S, Kubota H, Arimura K, Kawabata M, Osame M. HTLV-I-associated myelopathy: analysis of 213 patients based on clinical features and laboratory findings. J Neurovirol 1995; 1:50-61.